One promising approach to reduce hypoglycaemia risk involves developing glucose-responsive insulin delivery systems.10 These systems regulate insulin release based on blood glucose levels, enhancing release during hyperglycaemia and reducing it during hypoglycaemia. The gene discussed is INS; the disease is Hypoglycemia.